Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study | Zendy

Lorenzo Guglielmetti | Zendy; Nicolas Véziris | Zendy; Alexandra Aubry | Zendy; Florence Brossier | Zendy; Christine Bernard | Zendy; Wladimir Sougakoff | Zendy; Vincent Jarlier | Zendy; J. Robert | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study

Author(s) -

Lorenzo Guglielmetti,

Nicolas Véziris,

Alexandra Aubry,

Florence Brossier,

Christine Bernard,

Wladimir Sougakoff,

Vincent Jarlier,

J. Robert

Publication year - 2018

Publication title -

the international journal of tuberculosis and lung disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.103

H-Index - 110

eISSN - 1815-7920

pISSN - 1027-3719

DOI - 10.5588/ijtld.17.0387

Subject(s) - medicine , ethambutol , tuberculosis , drug resistance , extensively drug resistant tuberculosis , multiple drug resistance , virology , mycobacterium tuberculosis , pathology , microbiology and biotechnology , biology

Identification of extensively drug-resistant tuberculosis (XDR-TB) may be delayed because of the lack of availability of molecular testing for second-line drugs (SLDs). Early suspicion of XDR-TB is therefore necessary to avoid developing further drug resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research